💉 A rebrand for Sanofi Bangladesh; Biological E gets an mRNA license; Zydus’ Covid vax 66% effective

Apr 01, 2022

∙ Paid

Welcome to the weekend once again. The week ends the way it began – with a tiny “meh”.

In today’s Kable: Sanofi Bangladesh rebrands; Lupin gets observations from the FDA; A new drug registry for India; A new oath for Indian doctors; South Sudan gets $200 million from the World Bank.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.